Disease on EC 3.4.21.B41 - kallikrein 10
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
ACTH-Secreting Pituitary Adenoma
Human Kallikrein 10 Expression in Surgically Removed Human Pituitary Corticotroph Adenomas: An Immunohistochemical Study.
Adenocarcinoma
Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma.
Adenocarcinoma
Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
Barrett Esophagus
Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
Breast Neoplasms
Bioregulation of kallikrein-related peptidases 6, 10 and 11 by the kinin B? receptor in breast cancer cells.
Breast Neoplasms
Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Breast Neoplasms
Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
Breast Neoplasms
Glucocorticoid receptor-mediated expression of kallikrein 10 in human breast cancer cell lines.
Breast Neoplasms
Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance.
Breast Neoplasms
Human kallikrein 10 ELISA development and validation in breast cancer sera.
Breast Neoplasms
Identification of KLK10 as a therapeutic target to reverse trastuzumab resistance in breast cancer.
Breast Neoplasms
Intracellular signaling pathways regulate hormone-dependent kallikrein gene expression.
Breast Neoplasms
Kallikrein 10 (KLK10) methylation as a novel prognostic biomarker in early breast cancer.
Breast Neoplasms
NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells.
Breast Neoplasms
Smad signaling is required to maintain epigenetic silencing during breast cancer progression.
Breast Neoplasms
Steroid hormone regulation of the human kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter.
Carcinoma
Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Carcinoma
Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.
Carcinoma
Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
Carcinoma
Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues.
Carcinoma
Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma.
Carcinoma, Endometrioid
Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas.
Carcinoma, Hepatocellular
Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.
Carcinoma, Non-Small-Cell Lung
Frequent transcriptional inactivation of Kallikrein 10 gene by CpG island hypermethylation in non-small cell lung cancer.
Carcinoma, Ovarian Epithelial
Overexpression of kallikrein 10 in epithelial ovarian carcinomas.
Carcinoma, Ovarian Epithelial
Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma.
Carcinoma, Ovarian Epithelial
The association with age, human tissue kallikreins 6 and 10 and hemostatic markers for survival outcome from epithelial ovarian cancer.
Carcinoma, Papillary
Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas.
Carcinoma, Renal Cell
Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.
Carcinoma, Squamous Cell
Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues.
Colonic Neoplasms
The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer.
Colorectal Neoplasms
Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Colorectal Neoplasms
Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Colorectal Neoplasms
Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer.
Colorectal Neoplasms
Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancer.
Colorectal Neoplasms
[Expression and single nucleotide polymorphisms of kallikrein 10 in colorectal cancer]
Cysts
The association with age, human tissue kallikreins 6 and 10 and hemostatic markers for survival outcome from epithelial ovarian cancer.
Dermatitis, Atopic
Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients.
Esophageal Neoplasms
Upregulated KLK10 inhibits esophageal cancer proliferation and enhances cisplatin sensitivity in vitro.
Fibroadenoma
Kallikrein 10 (KLK10) methylation as a novel prognostic biomarker in early breast cancer.
Gastrointestinal Neoplasms
Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Infections
Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Laryngeal Neoplasms
Identification of molecular targets for immunotherapy of patients with head and neck squamous cell carcinoma.
Lung Neoplasms
Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues.
Lung Neoplasms
Frequent transcriptional inactivation of Kallikrein 10 gene by CpG island hypermethylation in non-small cell lung cancer.
Neoplasm Metastasis
Aberrant upregulation of KLK10 promotes metastasis via enhancement of EMT and FAK/SRC/ERK axis in PDAC.
Neoplasm Metastasis
Development of a survival prediction model for gastric cancer using serine proteases and their inhibitors.
Neoplasm Metastasis
Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer.
Neoplasm Metastasis
Frequent transcriptional inactivation of Kallikrein 10 gene by CpG island hypermethylation in non-small cell lung cancer.
Neoplasm Metastasis
MiR-199b-5p promotes tumor growth and metastasis in cervical cancer by down-regulating KLK10.
Neoplasm Metastasis
Transcriptional Suppression of miR-7 by MTA2 Induces Sp1-Mediated KLK10 Expression and Metastasis of Cervical Cancer.
Neoplasms
A 10-gene classifier for distinguishing head and neck squamous cell carcinoma and lung squamous cell carcinoma.
Neoplasms
Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Neoplasms
Aberrant upregulation of KLK10 promotes metastasis via enhancement of EMT and FAK/SRC/ERK axis in PDAC.
Neoplasms
Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Neoplasms
Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Neoplasms
Development of a survival prediction model for gastric cancer using serine proteases and their inhibitors.
Neoplasms
Diagnostic Value of Serum Kallikrein-Related Peptidases 6 and 10 Versus CA125 in Ovarian Cancer.
Neoplasms
Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
Neoplasms
Elevated tumor tissue protein expression levels of kallikrein-related peptidases KLK10 and KLK11 are associated with a better prognosis in advanced high-grade serous ovarian cancer patients.
Neoplasms
Epigenetic events of disease progression in head and neck squamous cell carcinoma.
Neoplasms
Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer.
Neoplasms
Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
Neoplasms
Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancer.
Neoplasms
Frequent transcriptional inactivation of Kallikrein 10 gene by CpG island hypermethylation in non-small cell lung cancer.
Neoplasms
Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance.
Neoplasms
Human Kallikrein 10 Expression in Surgically Removed Human Pituitary Corticotroph Adenomas: An Immunohistochemical Study.
Neoplasms
Identification of molecular targets for immunotherapy of patients with head and neck squamous cell carcinoma.
Neoplasms
Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker.
Neoplasms
Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast, testicular, and ovarian cancers.
Neoplasms
Kallikrein-related peptidase (KLK10) cessation blunts colorectal cancer cell growth and glucose metabolism by regulating the PI3K/Akt/mTOR pathway.
Neoplasms
Kallikrein-related peptidase 10 expression in salivary gland tissues and tumours.
Neoplasms
Kallikreins 5, 6 and 10 differentially alter pathophysiology and overall survival in an ovarian cancer xenograft model.
Neoplasms
Kallikreins as Markers of Disseminated Tumour Cells in Ovarian Cancer - A Pilot Study.
Neoplasms
KLK10 exon 3 unmethylated PCR product concentration: a new potential early diagnostic marker in ovarian cancer? - A pilot study.
Neoplasms
Methyl-binding domain protein 2-dependent proliferation and survival of breast cancer cells.
Neoplasms
Methylation of multiple genes as a candidate biomarker in non-small cell lung cancer.
Neoplasms
MiR-199b-5p promotes tumor growth and metastasis in cervical cancer by down-regulating KLK10.
Neoplasms
NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells.
Neoplasms
Polymorphisms in Kallikrein7 and 10 genes and oral cancer risks in Taiwan betel quid chewers and smokers.
Neoplasms
Prognostic significance of human tissue kallikrein-related peptidases 6 and 10 in gastric cancer.
Neoplasms
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
Neoplasms
Steroid hormone regulation of the human kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter.
Neoplasms
Structural basis for the Zn 2+ inhibition of the zymogen-like kallikrein-related peptidase 10.
Neoplasms
The association with age, human tissue kallikreins 6 and 10 and hemostatic markers for survival outcome from epithelial ovarian cancer.
Neoplasms
The human kallikrein 10 promoter contains a functional retinoid response element.
Neoplasms
Transcriptional Suppression of miR-7 by MTA2 Induces Sp1-Mediated KLK10 Expression and Metastasis of Cervical Cancer.
Neoplasms
Upregulated KLK10 inhibits esophageal cancer proliferation and enhances cisplatin sensitivity in vitro.
Neoplasms
Use tumor suppressor genes as biomarkers for diagnosis of non-small cell lung cancer.
Ovarian Neoplasms
Diagnostic Value of Serum Kallikrein-Related Peptidases 6 and 10 Versus CA125 in Ovarian Cancer.
Ovarian Neoplasms
Elevated tumor tissue protein expression levels of kallikrein-related peptidases KLK10 and KLK11 are associated with a better prognosis in advanced high-grade serous ovarian cancer patients.
Ovarian Neoplasms
Functional proteomics of kallikrein-related peptidases in ovarian cancer ascites fluid.
Ovarian Neoplasms
Identification of single nucleotide polymorphisms in the human kallikrein 10 (KLK10) gene and their association with prostate, breast, testicular, and ovarian cancers.
Ovarian Neoplasms
Kallikrein-related peptidase 10 (KLK10) expression and single nucleotide polymorphisms in ovarian cancer survival.
Ovarian Neoplasms
Kallikreins 5, 6 and 10 differentially alter pathophysiology and overall survival in an ovarian cancer xenograft model.
Ovarian Neoplasms
Kallikreins as Markers of Disseminated Tumour Cells in Ovarian Cancer - A Pilot Study.
Ovarian Neoplasms
Potential markers that complement expression of CA125 in epithelial ovarian cancer.
Ovarian Neoplasms
The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.
Ovarian Neoplasms
Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer.
Pancreatic Neoplasms
Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Pancreatic Neoplasms
In-silico analysis of kallikrein gene expression in pancreatic and colon cancers.
Pancreatic Neoplasms
Kallikrein-Related Peptidase 6 Is Associated with the Tumour Microenvironment of Pancreatic Ductal Adenocarcinoma.
Peutz-Jeghers Syndrome
Search for the second Peutz-Jeghers syndrome locus: exclusion of the STK13, PRKCG, KLK10, and PSCD2 genes on chromosome 19 and the STK11IP gene on chromosome 2.
Polycystic Kidney Diseases
Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker.
Prostatic Neoplasms
Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Prostatic Neoplasms
Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
Prostatic Neoplasms
Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker.
Prostatic Neoplasms
NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells.
Prostatic Neoplasms
The Role of Kallikrein10 (KLK10) Polymorphism in Prostate Cancer Susceptibility.
Psoriasis
Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy.
Stomach Neoplasms
Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Stomach Neoplasms
Identification of new splice variants and differential expression of the human kallikrein 10 gene, a candidate cancer biomarker.
Stomach Neoplasms
NES1/KLK10 promotes trastuzumab resistance via activation of PI3K/AKT signaling pathway in gastric cancer.
Stomach Neoplasms
Overexpression of kallikrein gene 10 is a biomarker for predicting poor prognosis in gastric cancer.
Uterine Cervical Neoplasms
MiR-199b-5p promotes tumor growth and metastasis in cervical cancer by down-regulating KLK10.
Uterine Cervical Neoplasms
Transcriptional Suppression of miR-7 by MTA2 Induces Sp1-Mediated KLK10 Expression and Metastasis of Cervical Cancer.
html completed